VIRACTA
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Feb 2021)
What this means for you
This application is over — abandoned 01 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87499368
- Mark type
- Stylized text
- Filed
- 21 Jun 2017
- Published for opposition
- 31 Oct 2017
- Abandoned
- 01 Feb 2021
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer
Owner
- Viracta Therapeutics, Inc., Cardiff, CA, US
- Viracta Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 01 Feb 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Feb 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2020 — SOU EXTENSION 5 GRANTED
- 23 Jun 2020 — SOU EXTENSION 5 FILED
- 09 Jul 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2020 — SOU TEAS EXTENSION RECEIVED
- 24 Sept 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2019 — SOU EXTENSION 4 GRANTED
- 20 Sept 2019 — SOU EXTENSION 4 FILED
- 20 Sept 2019 — SOU TEAS EXTENSION RECEIVED
- 20 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2019 — SOU EXTENSION 3 GRANTED
- 18 Jun 2019 — SOU EXTENSION 3 FILED
- 18 Jun 2019 — SOU TEAS EXTENSION RECEIVED